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A cross-sectional study evaluated the prevalence of and the risk factors for hepatitis C and B viruses among 700 adults above
the age of 40 years in a rural area of South Korea. Seropositivity for hepatitis C virus antibody (11.0%, 95% conﬁdence
interval: 8.7–13.6) was higher than that for hepatitis B surface antigen (4.4%, 95% conﬁdence interval: 3.0–6.2). Anti-hepatitis
C virus seropositivity was associated with a history of repeated acupuncture (odds ratio=2.1, 95% conﬁdence interval: 1.1–
4.0), and blood transfusion (odds ratio=5.5, 95% conﬁdence interval: 1.6–19.3) before 1992 when hepatitis C virus screening
in blood donors became mandatory. Hepatitis C virus 2a was the most prevalent genotype, followed by 1b. Hepatitis C virus
risk attributable to acupuncture was 38% (9% for men and 55% for women). Safer acupuncture practice has become a priority
for hepatitis C virus prevention in South Korea.
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Liver cancer mortality in South Korea is one of the highest in the
world at 30.3 and 9.7 per 100000 for men and women, respectively
(world age-standardised WHO, 1998). Both hepatitis B and C
viruses (HBV and HCV) infection are strong risk factors for the
development of liver cancer in South Korea (Shin et al, 1996), as
well as in other countries (IARC, 1994). In 1991, HBV was found
to be the most important risk factor for hepatocellular carcinoma
(HCC) in Korea (Yoo et al, 1991). Since then, however, HCV
infection has shown a stronger association in elderly HCC patients
(Lee et al, 1993; Huh et al, 1998).
Since the introduction of an HCV antibody (anti-HCV) test for
screening blood donors in Korea in April 1991, HCV exposure
among blood recipients has decreased. However, HCV transmission
may still be prevalent in certain areas, due to such practices as
acupuncture. Indeed, a history of acupuncture has been reported
by more than one third of subjects in a study in South Korea (Shin
et al, 2000). Major indications for acupuncture include arthritis
and other joint diseases, the sequelae of trauma, headache, and a
broad range of minor diseases not responding to conventional
medical treatments (http://www.acu.pe.kr).
A survey in 1993 in a rural district showed a high prevalence of
anti-HCV (5.5% among subjects over 10 years of age) and
suggested a role for parenteral viral exposure other than blood
transfusion (Shin et al, 2000). We therefore conducted a cross-
sectional study in a different part of the same rural area.
METHODS
Study area and subjects
The study area was in a rural part of south-east Korea (population
4500) where mortality rates for liver cancer are 120% and 50%
higher than the national average in men and women, respectively
(Lee et al, 2001). The majority of the population in the study area
is employed in agriculture, and their socio-cultural characteristics
are similar to those in other rural areas in Korea.
In 1999, the 2299 inhabitants of the area over 40 years of age
formed the target population for a survey in the preparation for
a large prospective cohort study (Yoo et al, 2002). The survey
aimed to assess the prevalence of, and risk factors for, infection
with HBV, HCV and Clonorchis sinensis. Subjects were not indivi-
dually invited, but were made aware of the survey by local health
authorities and village heads (e.g., through village meetings and
local broadcasting). Seven hundred subjects gave their informed
consent and underwent the survey (288 men and 412 women,
comprising 30.2% and 31.8% of male and female residents, respec-
tively). Among these were 146 couples thereby allowing study of
heterosexual transmission of HCV and HBV between spouses.
A structured questionnaire was completed for each individual by
trained interviewers covering demographic characteristics, medical
history including blood transfusion, acupuncture, smoking, and
drinking habits.
The total frequency of blood transfusion and acupuncture
sessions was evaluated. As screening for HCV among blood donors
started in Korea in April 1991, the study participants were asked to
report the year in which they ﬁrst received blood transfusion and
also acupuncture. Alcohol drinking was deﬁned as regularly
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www.bjcancer.comconsuming at least one alcoholic drink per month. Daily intake of
more than 80 grams of alcohol for more than 10 years was classi-
ﬁed as heavy drinking. Individuals who had smoked more than 20
packs of cigarettes prior to the survey were classiﬁed as smokers
and those who had smoked more than one pack per day for more
than 10 years were classiﬁed as heavy smokers.
Serological study
Serum samples, frozen at 7708C within 2 h of blood collection,
were tested for anti-HCV and hepatitis B surface antigen (HBsAg).
Anti-HCV was tested using the Abbott enzyme immunoassay (EIA)
kit, HBsAg using the EIA method. The liver enzymes, alanine
aminotransferase (ALT), and aspartame aminotransferase (AST)
were also evaluated.
Detection and genotyping of serum HCV RNA
Presence of HCV RNA viremia was conﬁrmed by nested reverse
transcript-polymerase chain reaction (RT–PCR), using Roche
Amplicor, the detection limit being 100 copies per ml. Hepatitis
C virus genotypes 1a, 1b, 2a, 2b and 3a were determined by ampli-
ﬁcation of the core region using genotype-speciﬁc primers as
described by Okamoto et al (1993).
Statistical analysis
Odds ratios (ORs) and corresponding 95% conﬁdence intervals
(CIs) of being seropositive for anti-HCV or HBsAg were computed
by means of unconditional multiple logistic regression analysis
including age, sex, education, smoking habits, and history of blood
transfusion and acupuncture (SAS Institute Inc, 1999). Linear
trends in risk according to the increase of exposure were evaluated
by likelihood ratio tests for trend based on linear logistic regression
models. Adjusted attributable risk fractions were computed
(Mezzetti et al, 1996).
RESULTS
Seroprevalence of anti-HCV and HBsAg
The seroprevalence of anti-HCV (11.0%, 95% CI: 8.7–13.6) was
higher than that of HBsAg (4.4%, 95% CI: 3.0–6.2) (Table 1).
Seropositivity of anti-HCV in women (14.1%) was more than
two-folds higher than in men (6.6%). The opposite was found
for HBsAg-positivity (6.6% in men, 2.9% in women). Seropositiv-
ity of anti-HCV increased with age (P for trend 50.001), while
seropositivity for HBsAg decreased (P=0.001) (Figure 1).
Risk factors for HCV infection
The association between seropositivity for anti-HCV and HBsAg
and selected characteristics is shown in Table 1. After adjustment
for all variables listed in Table 1, the crude OR of anti-HCV in
women decreased from 2.3 (95% CI: 1.3–4.0) to 1.3 (95% CI:
0.6–3.0). In contrast, the crude OR of HBsAg in women increased
from 0.4 (95% CI: 0.2–0.9) to 1.5 (95% CI: 0.4–5.1).
Whereas education was inversely associated with the risk for
anti-HCV seropositivity (OR for more than 10 years of education
vs none=0.3, 95% CI: 0.1–0.9), it was directly associated with
HBsAg seropositivity (OR=4.6, 95% CI: 1.1–19.1). Drinking alco-
hol was not signiﬁcantly associated with seropositivity for either
anti-HCV or HBsAg. An increased risk of borderline statistical
signiﬁcance was found for HBsAg among cigarette smokers (OR
for heavy smoker vs none=3.1, CI: 0.9–10.8). A history of blood
transfusion was not signiﬁcantly associated with seropositivity for
either anti-HCV or HBsAg.
Compared to individuals who had never been transfused, those
with a history of transfusion before 1992 had an increased risk
(OR=5.5, 95% CI: 1.6–19.3) for anti-HCV positivity but not for
HBsAg positivity (OR=1.5, 95% CI: 0.2–13.0) (Table 1). None
of the 10 recipients who were transfused in or after 1992 was posi-
tive for anti-HCV, but one subject was seropositive for HBsAg.
Only one individual reported having a transfusion more than once.
Blood volume was associated with seropositivity for neither anti-
HCV nor HBsAg. Whilst 13.3% of subjects with a history of
acupuncture were seropositive for anti-HCV, only 4.0% showed
HBsAg seropositivity. An association was found between acupunc-
ture and anti-HCV seropositivity (OR=1.9, 95% CI: 1.0–3.6), but
not HBsAg (OR=0.9). The increased risk from acupuncture did not
vary by year at ﬁrst exposure. OR for anti-HCV was higher among
those who underwent acupuncture twice or more (OR=2.1, 95%
CI: 1.1–4.0) than among those who had this only once
(OR=1.2) (Table 1).
HCV RNA genotype
HCV RNA was detected by RT–PCR in 51 (66.2%) of 77 anti-
HCV positive subjects. The detection rate of HCV RNA among
anti-HCV positive subjects was signiﬁcantly lower in women
(58.6%) than in men (84.2%). The most prevalent HCV genotype
was 2a followed by 1b. Most subjects with HCV RNA detected had
a history of acupuncture (Figure 2).
Inter-spousal transmission of HCV infection
In three of 146 couples who took part in this aspect of the study,
seropositivity for anti-HCV was found in both partners (Table 2).
In the only couple both partners were HCV RNA positive, HCV
genotypes were different. All six members of anti-HCV positive
concordant couples had a history of acupuncture. In only one
couple were both spouses seropositive for HBsAg, both with a
history of acupuncture, but not blood transfusion.
DISCUSSION
The major ﬁndings from our present study in South Korea are (1)
a high prevalence of anti-HCV seropositivity, more than double
that of HBsAg seropositivity and (2) that acupuncture is an impor-
tant cause of this. Acupuncture was associated with a doubling in
the prevalence of anti-HCV, but not of HBsAg.
As 34.1% of men and 62.9% of women reported having had an
acupuncture session more than once, the attributable risk fraction
for HCV infection was 38% (95% CI: 8.0–69.5) overall (9.4%,
95% CI: 0.5–67.3 among men and 54.5%, 95% CI: 21.2–87.8
among for women). In contrast, the risk fraction attributable to
blood transfusion was 4% (95% CI: 73.2–11.1).
Seroprevalence of HCV infection varies widely between and within
countries, ranging from 1–2% in most western countries (Dubois et
al, 1997; Alter et al, 1999; Goritsas et al, 2000), and in non-endemic
areas in Japan (Kiyosawa et al, 1994; Kayaba et al, 1998) to more than
15% in Egypt (Frank et al, 2000), Italy (Raffaele et al, 2001), and in
endemic areas of Japan (Kiyosawa et al, 1994).
The only efﬁcient route for HCV transmission is parenteral. As
the prevalence of blood transfusion in the general population is less
than 1%, high-risk areas for HCV are characterised by a relatively
high frequency of other parenteral treatments (e.g., intra-muscular
injections for minor conditions in Italy before disposable needles
and syringes became available, Raffaele et al, 2001).
Acupuncture, tattooing, and folk medicines have been associated
with an increased risk of HCV seropositivity in several studies from
Asia (see Kao and Chen, 2000, for a review), including Japan
(Michitaka et al, 1991; Kiyosawa et al, 1994), Taiwan (Sun et al,
1999), Indonesia (Sulaiman et al, 1995) and South Korea (Shin
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between 1.9 (Michitaka et al, 1991) and 3.3 (Shin et al, 2000)
and tended to increase with the increase in acupuncture sessions.
No increased risk of HCV infection after acupuncture, however,
was found in Japan, among atomic bomb survivors (Fujiwara et
al, 2000), the United Kingdom (Neal et al, 1994) and the United
States (Alter, 1999), though in Western countries the practice
was seldom reported (Alter, 1999). The proportion of people with
a history of acupuncture in our survey in South Korea (68%) is the
highest reported so far in any study.
Our estimate of HCV seropositivity agrees with a previous
survey (11% among adults over 40 years old) (Shin et al, 2000),
although it is higher than in other studies (Kim et al, 1992; Kim
et al, 1997; Seo and Lee, 1998) from South Korea.
Conversely, our present estimate of HBsAg seropositivity is simi-
lar to that found by the 1998 National Health and Nutrition Survey
in South Korea (KIHSA, 1999). In the mid-1980s a nationwide
campaign of HBV vaccination was initiated in the country, the
vaccine being mandatory for newborn children and recommended
to adults (Ahn, 1996).
Apart from acupuncture and blood transfusion before routine
HCV screening of blood donors, only a high educational level
was signiﬁcantly associated with HCV positivity in this study.
Interestingly, whereas the excess of HCV positivity in women
compared to men disappeared after allowance for acupuncture
history, the inverse association with years of education was
not modiﬁed. In fact, whereas women in South Korea showed
a three-fold increased risk to have had acupuncture compared
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Table 1 Seropositivity and corresponding odds ratio (ORs) and 95% conﬁdence intervals (CIs)
a for anti-HCV
and HBsAg according to selected characteristics, South Korea, 1999
No. of
Anti-HCV positivity HBsAg positivity
Variables tested n (%) OR (95% CI) n (%) OR (95% CI)
Age group
40–49 117 5 (4.3) 1.0 9 (7.7) 1.0
50–59 216 23 (10.6) 1.9 (0.7–5.4) 10 (4.6) 0.7 (0.3–1.8)
60–69 248 28 (11.3) 1.8 (0.6–5.2) 7 (2.8) 0.5 (0.2–1.6)
70 119 21 (17.7) 2.6 (0.8–8.1) 5 (4.2) 1.3 (0.3–4.9)
P for trend 50.01 0.17 0.11 0.82
Sex
Male 288 19 (6.6) 1.0 19 (6.6) 1.0
Female 412 58 (14.1) 1.3 (0.6–3.0) 12 (2.9) 1.5 (0.4–5.1)
Education
None 249 44 (17.7) 1.0 4 (1.6) 1.0
510 years 300 27 (9.0) 0.6 (0.3–1.1) 15 (5.0) 3.4 (0.96–11.9)
510 years 151 6 (4.0) 0.3 (0.1–0.9) 12 (8.0) 4.6 (1.1–19.1)
P for trend 50.01 0.02 50.01 50.05
Alcohol drinking
No 444 53 (11.9) 1.0 15 (3.3) 1.0
Moderate 155 18 (9.9) 1.3 (0.7–2.5) 9 (5.0) 1.1 (0.4–2.8)
Heavy 120 5 (7.8) 1.5 (0.5–4.6) 7 (10.9) 2.3 (0.8–7.2)
P for trend 0.26 0.3 50.01 0.2
Cigarette smoking
No 425 57 (13.4) 1.0 12 (2.8) 1.0
Moderate 155 13 (8.4) 0.7 (0.3–1.5) 8 (6.9) 1.8 (0.5–6.1)
Heavy 120 7 (5.8) 0.6 (0.2–1.6) 11 (9.2) 3.1 (0.9–10.8)
P for trend 50.01 0.2 50.01 0.07
Blood transfusion
No 662 70 (10.6) 1.0 29 (4.4) 1.0
Yes 38 7 (18.4) 1.8 (0.7–4.4) 2 (5.3) 1.6 (0.3–7.1)
Year
1992 and after 10 0 0 (0–1.3) 1 (10.0) 2.4 (0.2–21.5)
Before 1992 14 5 (35.7) 5.5 (1.6–19.3) 1 (7.1) 1.5 (0.2–13.0)
Not reported 14 2 (14.3) 1.1 (0.2–5.4) 0 0 (0–6.3)
Volume (L)
1 12 3 (25.0) 2.6 (0.7–10.5) 2 (16.7) 5.9 (1.1–30.9)
52 26 4 (15.4) 1.4 (0.4–4.3) 0 0 (0–2.2)
Acupuncture
No 227 14 (6.2) 1.0 12 (5.3) 1.0
Yes 473 63 (13.3) 1.9 (1.02–3.6) 19 (4.0) 0.9 (0.4, 2.0)
Year
1992 and after 238 36 (15.2) 2.4 (1.2–4.5) 11 (4.6) 1.0 (0.4, 2.0)
Before 1992 98 17 (17.4) 3.0 (1.4–6.7) 4 (4.1) 0.8 (0.2, 2.5)
Not exact 137 10 (7.3) 0.8 (0.4–2.0) 4 (2.9) 0.8 (0.2, 2.6)
Frequency
Once 87 7 (8.1) 1.2 (0.4–3.0) 5 (5.8) 1.1 (0.3–3.4)
52 sessions 386 56 (14.5) 2.1 (1.1–4.0) 14 (3.6) 0.8 (0.4–2.0)
P for trend 50.01 0.02
Total 700 77 (11.0) (8.7–13.6) 31 (4.4) (3.0–6.2)
aAdjusted for age, sex, education, drinking, smoking, blood transfusion, and acupuncture, as appropriate.
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to educational level.
The association with HCV seropositivity in our survey was
stronger among those who underwent acupuncture twice or more
than those who had it only once and was, therefore, unlikely to be
due to chance. The association with HCV following ﬁrst acupunc-
ture after 1991 suggested that the transmission risk has persisted in
recent years.
Possible bias and confounding factors may be relevant. Selection
bias is of concern, as only one third of the population joined our
health survey. The prevalence of HCV and, possibly, the association
with acupuncture history might have been overestimated in our
survey if people with liver disease or those being afraid of the
possible dangers of acupuncture had selectively accepted to partici-
pate. We had, however, information on liver enzymes and found a
high HCV seropositivity (5.4% in men, 11.5% in women) also
among participants whose ALT levels were normal (79.4% in
men and 90.2% in women). Furthermore, in 1999 there was no
widespread awareness of the possible danger of acupuncture in
the general population in Korea and the level of use of acupunc-
ture we report, is consistent with a previous survey (Shin et al,
2000). A confounding effect of parenteral treatments other than
acupuncture and blood transfusion is difﬁcult to rule out. Frequent
users of acupuncture are likely to suffer from diseases which might
have also led to frequent intra-muscular injections or hospital
admissions before universal availability of disposable syringes and
needles.
In conclusion, although a fraction of HCV infections among
people who underwent acupuncture may be due to other routes
of parenteral transmission, we did ﬁnd that a history of acupunc-
ture was very frequent in South Korea and contributes to the high
proportion of HCV seropositivity that we detected, especially
among women. Safer acupuncture practice (i.e., use of disposable
needles) represents, therefore, a high public health priority in
South Korea and requires a close monitoring of acupuncturists
nationwide.
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Figure 1 Seropositivity of anti-HCV (A) and HBsAg (B) among men
and women, South Korea, 1999.
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Figure 2 Distribution of HCV seropositive subjects by presence of HCV
RNA, genotypes, and acupuncture history in men (A) and women (B),
South Korea, 1999.
Table 2 Concordance of seropositivity for anti-HCV and HBsAg be-
tween spouses, South Korea, 1999
Husband
Wife Positive Negative Total
Anti-HCV
Positive 3
a 16 19
Negative 7 120 127
Total 10 136 146
McNemar’s test=3.52 P=0.06
HBsAg
Positive 1
b 67
Negative 10 129 139
Total 11 135 146
McNemar’s test=1.0 P=0.32
aHCV RNA genotype and risk factors of three couples; Couple 1: husband HCV
RNA negative, blood transfusion history positive, wife genotype 1b; Couple 2:
husband genotype 1b, wife genotype 2a; Couple 3: husband and wife both HCV
RNA negative; All six subjects had a history of acupuncture.
bHusband and wife
had a history of acupuncture, but not of transfusion.
HBV, HCV and the role of acupuncture in South Korea
HR Shin et al
317
ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(3), 314–318REFERENCES
Ahn YO (1996) Strategy for vaccination against hepatitis B in areas with high
endemicity: focus on Korea. Gut 38: S63–S66
Alter MJ (1999) Hepatitis C virus infection in the United States. J Hepatol 31:
88–91
Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA,
Kaslow RA, Margolis HS (1999) The prevalence of hepatitis C virus infec-
tion in the United States, 1988 through 1994. N Engl J Med 341: 556–562
Dubois F, Desenclos J, Mariotte N, Goudeau A (1997) Hepatitis C in a French
population-based survey, 1994: seroprevalence, frequency of viremia,
genotype distribution, and risk factors. The Collaborative Study Group.
Hepatology 25: 1490–1496
Fujiwara S, Kusumi S, Cologne J, Akahoshi M, Kodama K, Yoshizawa H
(2000) Prevalence of anti-hepatitis C virus antibody and chronic liver
disease among atomic bomb survivors. Radiat Res 154: 12–19
Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS,
El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I (2000) The
role of parenteral antischistosomal therapy in the spread of hepatitis C
virus in Egypt. Lancet 355: 887–891
Goritsas C, Plerou I, Agaliotis S, Spinthaki R, Mimidis K, Velissaris D, Lazar-
ou N, Labropoulou-Karatza C (2000) HCV infection in the general
population of a Greek island: prevalence and risk factors. Hepatogastroen-
terology 47: 782–785
Huh K, Choi SY, Whang YS, Lee DS (1998) Prevalence of viral hepatitis
markers in Korean patients with hepatocellular carcinoma. J Korean Med
Sci 13: 306–310
IARC (1994) IARC monographs on the evaluation of carcinogenic risks to
humans, Vol. 59, Hepatitis viruses. Lyon: International Agency for Research
on Cancer
Kao JH, Chen DS (2000) Transmission of hepatitis C virus in Asia: past and
present perspectives. J Gastroenterol Hepatol 15:(Suppl):): E91–E96
Kayaba K, Igarashi M, Okamoto H, Tsuda F (1998) Prevalence of anti-hepa-
titis C antibodies in a rural community without high mortality from liver
disease in Niigata prefecture. J Epidemiol 8: 250–255
KIHSA (1999) Report of National Health and Nutrition Survey 1998. Seoul:
Korea Institute for Health and Social Affairs
Kim MS, Seo KS, Kim NJ, Choi SK, Suh SP, Choi JS, Kim SJ (1997) A study
on the positivities of anti-HCV by second-generation ELISA in rural area
of Chonnam Province. Korean J Int Med 53: 741–746
Kim YS, Pai CH, Chi HS, Kim DW, Min YI, Ahn YO (1992) Prevalence of
hepatitis C virus antibody among Korean adults. J Korean Med Sci 7:
333–336
Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K, Imai H,
Nakano Y, Usuda S, Uemura K, Furuta S, Watanabe Y, Watanabe J, Fuku-
da Y, Takayama Y (1994) Transmission of hepatitis C in an isolated area in
Japan: community-acquired infection. The South Kiso Hepatitis Study
Group. Gastroenterology 106: 1596–1602
Lee DH, Kim JH, Han BH, Lee SO, Shin HR, Jung IC (2001) Geographical
variation of liver cancer mortality in Korea (1992–1998). Cancer Res
Treatment 33: 420–426
Lee HS, Han CJ, Kim CY (1993) Predominant etiologic association of hepa-
titis C virus with hepatocellular carcinoma compared with hepatitis B virus
in elderly patients in a hepatitis B-endemic area. Cancer 72: 2564–2567
Mezzetti M, Ferraroni M, Decarli A, La Vecchia C, Benichou J (1996) Soft-
ware for attributable risk and conﬁdence interval estimation in case-
control studies. Comput Biomed Res 29: 63–75
Michitaka K, Horiike N, Ohta Y (1991) An epidemiological study of hepatitis
C virus infection in a local district in Japan. Rinsho Byori 39: 586–591
Neal KR, Jones DA, Killey D, James V (1994) Risk factors for hepatitis C virus
infection. A case-control study of blood donors in the Trent Regions (UK).
Epidemiol Infect 112: 595–601
Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H,
Mishiro S (1993) Characterization of the genomic sequence of type V
(or 3a) hepatitis c virus isolates and PCR primers for speciﬁc detection.
J Gen Virol 74: 2385–2390
Raffaele A, Valenti M, Iovenitti M, Matani A, Bruno ML, Altobelli E, D’Ales-
sandro A, Barnabei R, Leonardis B, Taglieri G (2001) High prevalence of
HCV infection among the general population in a rural area of central
Italy. Eur J Epidemiol 17: 41–46
SAS Institute Inc (1999) SAS/STAT User’s Guide, Version 8. Vol. 2. Cary,
North Carolina: SAS Institute Inc.
Seo TS, Lee SS (1998) A study on positive of HBsAg, HBsAB and anti-HCV in
Korean adults. Korean J blood Transfu 9: 257–272
Shin HR, Kim JY, Ohno T, Cao K, Mizokami M, Risch H, Kim SR (2000)
Prevalence and risk factors of hepatitis C virus infection among Koreans
in a rural area of Korea. Hepatology Research 17: 185–196
Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, Ahn YO, Shigemas-
tu T (1996) Hepatitis B and C virus, Clonorchis sinensis for the risk of liver
cancer: a case-control study in Pusan, Korea. Int J Epidemiol 25: 933–940
Sulaiman HA, Julitasari, Sie A, Rustam M, Melani W, Corwin A, Jennings GB
(1995) Prevalence of hepatitis B and C viruses in healthy Indonesian blood
donors. Trans R Soc Trop Med Hyg 89: 167–170
Sun C, Chen H, Lu C, You S, Mau Y, Ho M, Lin S, Chen C (1999) Transmis-
sion of hepatitis C virus in Taiwan: prevalence and risk factors based on a
nationwide survey. J Med Virol 59: 290–296
WHO (1998) 1996 World Health Statistics. Geneva: World Health Organiza-
tion
Yoo KY, Heon K, Lee MS, Park BJ, Ahn YO, Lee HS, Kim CY, Park TS (1991)
A reconstructed cohort study on the hepatitis B virus infection as a risk
factor of liver cancer in Korea. J Korean Med Sci 6: 319–324
Yoo KY, Shin HR, Chang SH, Lee KS, Park SK, Lee DH the KMCC Study
Group (2002) Korean multi-center cancer cohort study: including a biolo-
gical material bank (KMCC-1). Asian Paciﬁc Journal of Cancer Prevention
3: 85–92
E
p
i
d
e
m
i
o
l
o
g
y
HBV, HCV and the role of acupuncture in South Korea
HR Shin et al
318
British Journal of Cancer (2002) 87(3), 314–318 ã 2002 Cancer Research UK